Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Agid

Showing results (91-100 of 611) with videos related to

Pageof 62
Sort By:
Neurology|January 5, 2002
Paroxysmal dystonia (tonic spasm) in multiple sclerosisE Waubant, P Alizé, A Tourbah, et al.
Brain Research|December 30, 1994
Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?A Mouatt-Prigent, Y Agid, E C Hirsch
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1992
The IMAO-B MDL 72.974 A in Parkinson's diseaseR Marconi, A M Bonnet, M Vidailhet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 25, 1998
Pathology of symptomatic tremorsM Vidailhet, C P Jedynak, P Pollak, et al.
Histology and Histopathology|July 1, 1997
Apoptosis in dopaminergic neurons of the human substantia nigra during normal agingP Anglade, S Vyas, E C Hirsch, et al.
Journal of Neural Transmission|January 1, 1973
Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the ratF Javoy, M B Youdim, Y Agid, et al.
Journal of Neurochemistry|February 1, 1980
Regional distribution of neurotransmitter synthesizing enzymes in the basal ganglia of human brainP Gaspar, F Javoy-Agid, A Ploska, et al.
Revue Neurologique|October 1, 1979
[Influence of choline on amnesia in Alzheimer's disease (author's transl)]A Whiteley, J L Signoret, Y Agid, et al.
Neurology|February 1, 1995
Dopamine denervation, age of onset, and Parkinson's diseaseM Ruberg, D Scherman, F Javoy-Agid, et al.
Neurology|May 1, 1996
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?P Damier, A Kastner, Y Agid, et al.
Pageof 62

Showing results (91-100 of 611) with videos related to

Sort By:
Pageof 62
Neurology|January 5, 2002
Paroxysmal dystonia (tonic spasm) in multiple sclerosisE Waubant, P Alizé, A Tourbah, et al.
Brain Research|December 30, 1994
Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?A Mouatt-Prigent, Y Agid, E C Hirsch
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1992
The IMAO-B MDL 72.974 A in Parkinson's diseaseR Marconi, A M Bonnet, M Vidailhet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 25, 1998
Pathology of symptomatic tremorsM Vidailhet, C P Jedynak, P Pollak, et al.
Histology and Histopathology|July 1, 1997
Apoptosis in dopaminergic neurons of the human substantia nigra during normal agingP Anglade, S Vyas, E C Hirsch, et al.
Journal of Neural Transmission|January 1, 1973
Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the ratF Javoy, M B Youdim, Y Agid, et al.
Journal of Neurochemistry|February 1, 1980
Regional distribution of neurotransmitter synthesizing enzymes in the basal ganglia of human brainP Gaspar, F Javoy-Agid, A Ploska, et al.
Revue Neurologique|October 1, 1979
[Influence of choline on amnesia in Alzheimer's disease (author's transl)]A Whiteley, J L Signoret, Y Agid, et al.
Neurology|February 1, 1995
Dopamine denervation, age of onset, and Parkinson's diseaseM Ruberg, D Scherman, F Javoy-Agid, et al.
Neurology|May 1, 1996
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?P Damier, A Kastner, Y Agid, et al.
Pageof 62